Compare Compass Inc. Class A Common Stock (COMP) vs Kenvue Inc. Common Stock (KVUE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Compass Inc. Class A Common Stock vs Kenvue Inc. Common Stock — how do they compare? Compass Inc. Class A Common Stock trades at $9.52 (market cap $7.05B), while Kenvue Inc. Common Stock trades at $17.88 (market cap $33.67B). The key difference: Kenvue Inc. Common Stock is far larger — about 4.8× Compass Inc. Class A Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.79% dividend while Compass Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| COMP | KVUE | |
|---|---|---|
Market Cap | $7.05B | $33.67B |
Volume | 15,310,192 | 11,878,502 |
Sector | Real Estate | Consumer Staples |
52-Week High | $13.58 | $19.83 |
52-Week Low | $6.68 | $14.11 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $10.47B | $41.17B |
Dividend Yield | — | 4.79% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Compass Inc. Class A Common Stock
Compass is a technology-enabled residential real estate company. Its platform provides agents with tools for customer relationships, marketing, client service, and transactions, alongside brokerage, title, escrow, and mortgage services.
Read more on COMP →About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →
